Answer
In Qdenga clinical studies involving people aged 4–60 years, the most frequently reported reactions were injection site pain (50%), headache (35%), myalgia (31%), injection site erythema (27%), malaise (24%), asthenia (20%) and fever (11%).
Sources for this answer
- Qdenga powder and solvent for solution for injection in pre-filled syringeTakeda UK Ltd · emc · SmPC §4.8 Undesirable effects · Version 7Document updated
Sources checked